17.59
Schrodinger Inc stock is traded at $17.59, with a volume of 947.35K.
It is down -4.71% in the last 24 hours and up +9.05% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$18.46
Open:
$18.46
24h Volume:
947.35K
Relative Volume:
0.75
Market Cap:
$1.32B
Revenue:
$254.91M
Net Income/Loss:
$-103.48M
P/E Ratio:
-12.53
EPS:
-1.4036
Net Cash Flow:
$-148.35M
1W Performance:
-3.14%
1M Performance:
+9.05%
6M Performance:
+54.30%
1Y Performance:
-9.56%
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SDGR
Schrodinger Inc
|
17.59 | 1.39B | 254.91M | -103.48M | -148.35M | -1.4036 |
|
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Sc - GuruFocus
SDGR Assumed by UBS -- Price Target Raised to $19.00 - GuruFocus
UBS Maintains Schrodinger(SDGR.US) With Hold Rating, Maintains Target Price $19 - Moomoo
UBS Adjusts Schrodinger PT to $19 From $13, Maintains Neutral Rating - marketscreener.com
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Two New Schrödinger Hires Get Stock Awards Vesting Over Four Years - Stock Titan
UBS initiates Schrodinger stock coverage with neutral rating - Investing.com
Schrodinger, Inc. Stock 12‑Month Price Target Raised to $21.83, Implies 18% Upside - TradingView
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR) - The Globe and Mail
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo! Finance Canada
Schrödinger (SDGR) Q2 2026 Earnings Call Transcript - AOL.com
Quantinno Capital Management LP Buys Shares of 174,095 Schrodinger, Inc. $SDGR - MarketBeat
Schrödinger (SDGR) Is Up 19.2% After AI Pact With BMS And Q2 ProfitabilityHas The Bull Case Changed? - simplywall.st
Schrödinger Unveils Bunsen, an AI Co-Scientist for Enhanced Molecular Discovery - SynBioBeta
Layoff Tracker: Aura, Schrödinger trim workforces - BioSpace
Dimensional Fund Advisors LP Cuts Holdings in Schrodinger, Inc. $SDGR - MarketBeat
The Bull Case For Bristol Myers Squibb (BMY) Could Change Following Expanded Schrödinger Bunsen AI Partnership - Sahm
Schrödinger, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - 富途牛牛
Results: Schrödinger, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Schrodinger (NASDAQ:SDGR) Raised to "Hold" at Wall Street Zen - MarketBeat
Schrodinger Inc (SDGR) Stock Analysis & Forecast - TradingKey
Schrodinger Inc (SDGR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Schrodinger Inc. (SDGR) Dips 0.95% to $17.64 as Shares Sit Between Support and ResistanceHigh Low Breadth - dars.gov.et
Schrödinger expands partnership with Bristol Myers Squibb - Investing.com Nigeria
BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Schrodinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery - marketscreener.com
Schrödinger Q2 2026 slides: AI launch, Ajax milestone drive beat By Investing.com - Investing.com South Africa
Schrödinger, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SDGR) 2026-08-06 - Seeking Alpha
SDGR Looks 36.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
SDGR SWOT Analysis: Key Financial Insights from 10-Q Filing - GuruFocus
Schrodinger Inc (SDGR) (Q2 2026) Earnings Call Highlights: ACV S - GuruFocus
Schrödinger (SDGR) Is Up 8.5% After AI Co‑Scientist Deal With BMS And Q2 Profitability Shift – Has The Bull Case Changed? - Yahoo Finance
Schrodinger Q2 Earnings Call Highlights - MarketBeat
Schrodinger Inc (SDGR) (Q2 2026) Earnings Call Highlights: ACV Surges 27% on Bunsen Launch and ... - Yahoo! Finance Canada
Earnings call transcript: Schrödinger beats Q2 2026 forecasts as shares rise - Investing.com South Africa
Schrodinger (NASDAQ:SDGR) Announces Quarterly Earnings Results - MarketBeat
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Schrödinger : Schrödinger 2Q26 Supplemental Slides - marketscreener.com
Is Schrodinger Inc (SDGR) Undervalued After Q2 Earnings Reveal $58.9 Million Revenue? GF Score: 73/100 - GuruFocus
Schrodinger Inc reports results for the quarter ended June 30Earnings Summary - TradingView
SDGR: Q2 2026 delivered 27% ACV growth, $58.9M revenue, and accelerated AI-driven innovation - TradingView
Q2 2026 Schrodinger Inc Earnings Call Transcript - GuruFocus
Schrodinger Q2 revenue beats estimates, swings to profit - TradingView
SDGR: 2Q26 revenue up 7.5% year-over-year, with drug discovery revenue surging 65% - TradingView
SDGR: Q2 2026 delivered 27% ACV growth, a return to profitability, and raised FY guidance - TradingView
Schrödinger Reports Second Quarter 2026 Financial Results - marketscreener.com
Schrodinger, Inc. 2026: Revenue $58.89M, EPS $0.08— 10-Q Summary - TradingView
Schrödinger, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BRIEF-Schrodinger Q2 Revenue USD 58.889 Million Vs. IBES Estimate USD 47.2 Million - TradingView
SDGR: Q2 2026 delivered 27% ACV growth, Bunsen AI launch, and improved profitability - TradingView
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):